Claire Malley

Claire Malley

Auto-generated profile, based on publicly available information

Claire Malley

National Center for Advancing Translational Sciences (NCATS), Stem Cell Translation Laboratory (SCTL), National Institutes of Health (NIH), Rockville, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YCYu Chen
Yu Chen
CTCarlos A. Tristan
Carlos A. Tristan
LCLu Chen
Lu Chen
VJVukasin M. Jovanovic
Vukasin M. Jovanovic
CMClaire Malley
Claire Malley
ISIlyas Singeç
Ilyas Singeç

1 June 2019 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
AWAlexandra Winters
Alexandra Winters
HBHenry T. Bahnson
Henry T. Bahnson
IRIngo Ruczinski
Ingo Ruczinski
MBMeher P. Boorgula
Meher P. Boorgula
CMClaire Malley
Claire Malley
RMRasika A. Mathias
Rasika A. Mathias

1 May 2016 in Molecular Phylogenetics and Evolution
Verified
Journal Article
Closed access
MJMatthew G. Johnson
Matthew G. Johnson
CMClaire Malley
Claire Malley
BGBernard Goffinet
Bernard Goffinet
ASA. Jonathan Shaw
A. Jonathan Shaw
NWNorman J. Wickett
Norman J. Wickett

6 May 2020 in Stem Cell Research
Verified
Journal Article
Open access
KKKanika Kanchan
Kanika Kanchan
KIKruthika Iyer
Kruthika Iyer
LYLisa R Yanek
Lisa R Yanek
ICIvan Carcamo-Orive
Ivan Carcamo-Orive
MTMargaret A Taub
Margaret A Taub
RMRasika A Mathias
Rasika A Mathias
Human induced pluripotent stem cell (hiPSC) lines have previously been generated through the NHLBI sponsored NextGen program at nine individual study sites. Here, we examined the structural integrity of 506 hiPSC lines as determined by copy number variations (CNVs). We observed that 149 hiPSC lines acquired 258 CNVs relative to donor DNA. We identified six recurrent regions of CNVs on chromosomes 1, 2, 3, 16 and 20 that overlapped with cancer associated genes. Furthermore, the genes mapping to regions of acquired CNVs show an enrichment in cancer related biological processes (IL6 production) and signaling cascades (JNK cascade & NFκB cascade). The genomic region of instability on chr20 (chr20q11.2) includes transcriptomic signatures for cancer associated genes such as ID1, BCL2L1, TPX2, PDRG1 and HCK. Of these HCK shows statistically significant differential expression between carrier and non-carrier hiPSC lines. Overall, while a low level of genomic instability was observed in the NextGen generated hiPSC lines, the observation of structural instability in regions with known cancer associated genes substantiates the importance of systematic evaluation of genetic variations in hiPSCs before using them as disease/research models.

13 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
KBKapil Bharti
Kapil Bharti
MSMin Jae Song
Min Jae Song
RQRussell Quinn
Russell Quinn
ENEric Nguyen
Eric Nguyen
TPTea Soon Park
Tea Soon Park
MFMarc Ferrer
Marc Ferrer
Age-related macular degeneration (AMD), a leading cause of blindness, initiates in the outer-blood-retina-barrier (oBRB) formed by Retinal pigment epithelium (RPE), Bruch’s membrane, and choriocapillaris. The mechanism of AMD initiation and progression remain poorly understood due to the lack of physiologically relevant oBRB models. We engineered a native-like 3D-oBRB tissue by bioprinting endothelial cells, pericytes, and fibroblasts on the basal side of a biodegradable scaffold and establishing an RPE monolayer on top. In this 3D-oBRB, a fully-polarized RPE monolayer with apical processes and basal infoldings provides barrier resistance, induces fenestration and choroid-specific gene expression in the choriocapillaris, and supports the formation of a Bruch’s-like membrane that allows tissue integration in rat eyes. Complement activation in the 3D-oBRB triggers dry-AMD phenotypes (including subRPE drusen and choriocapillaris degeneration), and hypoxia activated HIF-α induces wet-AMD phenotypes (choriocapillaris neovascularization). Anti-VEGF drug treatment suppresses neovascularization - validating this model for clinical translation and drug discovery.